Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Incyte Corporation
Study ID
NCT05919511
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional — OTHER
    This is an observational study

Study Details

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Key Dates

Start date
Aug 1, 2023
Status verified
Mar 2026
Primary completion
Oct 15, 2027
Completion
Oct 15, 2027

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: At risk for GVHD
    Equal or Greater than 18 years old post alloSCT

Primary Outcome Measure

Overall Burden of cGVHD diagnosis and severity [ Time Frame: 36 months ]

Central Contacts

Locations (32)

FacilityCityStateZIPSite coordinators
University of Alabama BirminghamBirminghamAlabama35294-
Mayo Clinic ArizonaPhoenixArizona85054-
City of HopeDuarteCalifornia91010-
USC Norris Comprehensive Cancer CenterLos AngelesCalifornia90033-
University of ColoradoAuroraColorado80309-
Mayo Clinic JacksonvilleJacksonvilleFlorida32224-
AdventHealth OrlandoOrlandoFlorida32803-
Moffit Cancer CenterOrlandoFlorida33612-
Emory UniversityAtlantaGeorgia30322-
Georgia Cancer CenterAugustaGeorgia30912-
Northwestern UniversityChicagoIllinois60611-
Rush University Medical GroupChicagoIllinois60612-
The University of ChicagoChicagoIllinois60637-
Loyola University Medical CenterMaywoodIllinois60153-
The University of Kansas Clinical Research CenterFairwayKansas66205-
Tulane Cancer CenterNew OrleansLouisiana70112-
University of Maryland Medical CenterBaltimoreMaryland21201-
Massachusetts Cancer Research CenterBostonMassachusetts02114-
Corewell HealthGrand RapidsMichigan49503-
Mayo Clinic RochesterRochesterMinnesota55905-
Rutgers Cancer Institute of New JerseyNew BrunswickNew Jersey08602-
Memorial Sloan Kettering Cancer CenterNew YorkNew York10021-
University of North Carolina at Chapel HillChapel HillNorth Carolina27514-
Levine Cancer InstituteCharlotteNorth Carolina28204-
The Ohio State UniversityColumbusOhio43201-
Oregon Health Sciences UniversityPortlandOregon97239-
Geisinger Health SystemsDanvillePennsylvania17822-
Vanderbilt University Medical CenterNashvilleTennessee37212-
Texas Oncology-Baylor Charles A. Sammons Cancer CenterDallasTexas75246-
University of Utah, Huntsman Cancer InstituteSalt Lake CityUtah84112-
Fred Hutchinson Cancer Research CenterSeattleWashington98109-
Medical College of WisconsinMilwaukeeWisconsin53226-

Find similar trials in Birmingham, AL

Related Studies